Government grants are available for Australian businesses in the biotechnology sector. Programs span federal and state governments, offering funding for growth, innovation, infrastructure and workforce development.
What these grants can fund
- Business expansion and capital investment
- Equipment and infrastructure upgrades
- Workforce training and skills development
- Technology adoption and innovation
- Export and market development
Common eligibility requirements
- Registered Australian business with a valid ABN
- Must be operating in the relevant sector
- Matching co-contribution may be required
- Some programs have employee or turnover thresholds
Eligibility varies by program. Always check the official source before applying.
Open programs
Showing 8 of 8A grant program supporting not-for-profit Industry Partner Organisations to provide specialised sectoral advice and expertise to businesses in the Industry Growth Program. These organisations leverage their sectoral expertise in priority areas identified by the National Reconstruction Fund to help businesses commercialise and grow, complementing one-on-one advisory services provided to eligible SMEs.
This project aims to apply advances in RNA and peptide chemistry to develop a new generation of precision medicines with potential to modify disease in FacioScapuloHumoral Dystrophy (FSHD). The innovation addresses barriers to systemic delivery, muscle and cell uptake, stability and safety. The project will generate proof of concept for muscle targeting of precision therapeutics in relevant models of FSHD.
The Cell Therapy Manufacturing Cooperative Research Centre (CTM CRC) is funded by the Australian Government to develop innovative cell therapy manufacturing technologies. The CRC focuses on creating stem cell delivery systems for chronic wound treatment and developing scalable production methods for immune cell therapies used in cancer and other medical conditions.
AUSCEP is designed to empower clinicians with an entrepreneurial spirit to bridge the gap between healthcare and innovation. The program offers a blend of immersive in-person pitstops, webinars, and access to a network of seasoned mentors to help clinicians transform groundbreaking ideas into impactful solutions across Medtech, Digital Health, Biotechnology, and Service Delivery.
A tax incentive program that supports companies conducting research and development activities in Australia. The RDTI enables companies to take risks and perform experiments where outcomes are uncertain, helping to build research infrastructure and attract investment in sectors like biotechnology.
A program that provides investment capital through registered pooled development funds to support business growth and expansion. The program is closed to new applicants but maintains a list of registered funds that invest in various sectors including technology, biotechnology, pharmaceuticals, and early-stage companies.
The fourth round of the mRNA Victoria Research Acceleration Fund (mVRAF Program) will provide $1.7 million to support mRNA-based medicines r... Grants of up to $500,000 for mRNA-based prophylactic or therapeutics projects that can show a pathway to translation or secure devel... Closed on 1 Nov 2024
One-off of grants up to $500,000 are now available to support research into the development new RNA and mRNA-based vaccines and therapeutics... Grants of up to $100,000 (Tier 1) for early-stage RNA-based therapeutic research projects, including discovery, early-stage and pre-... Closed on 15 Dec 2023
Grant information is sourced from official government websites and updated regularly. Program details, eligibility and closing dates change — always verify with the official source before applying. Last data update: February 2026.